Medicare Enrolled

Dr. Neal Blauzvern, D.O.

Pain Medicine · Austin, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
8015 SHOAL CREEK BLVD STE 103, Austin, TX 78757
5124677246
In practice since 2005 (20 years)
NPI: 1609873603 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Blauzvern from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Blauzvern? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Blauzvern

Dr. Neal Blauzvern is a pain medicine specialist in Austin, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Blauzvern performed 1,890 Medicare services across 1,405 unique beneficiaries.

Between the years covered by Open Payments, Dr. Blauzvern received a total of $10,829 from 59 pharmaceutical and/or device companies across 393 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Blauzvern is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 38% volume in TX $10,829 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,890
Medicare services
Top 38% in TX for pain medicine
1,405
Unique beneficiaries
$121
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~94 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Drug screening test 630 $61 $600
Office visit, established patient (30-39 min) 337 $98 $765
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 313 $241 $1,300
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 241 $194 $1,300
Office visit, established patient (20-29 min) 224 $66 $519
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 131 $153 $1,300
New patient office visit (30-44 min) 14 $82 $765
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,829
Total received (2018-2024)
Avg $1,547/year across 7 years
Top 23% in TX for pain medicine
59
Companies
393
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,065 (92.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$764 (7.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$48
2023
$1,389
2022
$1,599
2021
$1,894
2020
$1,235
2019
$2,312
2018
$2,352

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,735
Nevro Corp.
$1,219
Amgen Inc.
$834
Medinc of Texas
$764
Collegium Pharmaceutical, Inc.
$549
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$424
Relievant Medsystems, Inc.
$370
Pernix Therapeutics Holdings, Inc.
$361
Biohaven Pharmaceuticals, Inc.
$355
AbbVie Inc.
$309
Teva Pharmaceuticals USA, Inc.
$309
Scilex Pharmaceuticals Inc.
$249
Biohaven Pharmaceutical Holding Company Ltd.
$229
Boston Scientific Corporation
$214
BioDelivery Sciences International, Inc.
$212
BOSTON SCIENTIFIC CORPORATION
$181
ABBVIE INC.
$167
PFIZER INC.
$159
SI-BONE, Inc.
$155
Novartis Pharmaceuticals Corporation
$144
Arbor Pharmaceuticals, Inc.
$136
Almatica Pharma LLC
$132
ARBOR PHARMACEUTICALS, INC.
$119
AbbVie, Inc.
$110
GRT US Holding, Inc.
$103
Medtronic, Inc.
$103
RedHill Biopharma Inc.
$100
Daiichi Sankyo Inc.
$68
Shionogi Inc
$64
Spinal Simplicity, LLC
$59
Zyla Life Sciences, Inc.
$57
Lilly USA, LLC
$54
SCILEX PHARMACEUTICALS INC.
$53
IBSA Pharma Inc.
$51
Stimwave Technologies Incorporated
$51
IMPEL PHARMACEUTICALS INC.
$46
Assertio Therapeutics, Inc.
$44
Allergan, Inc.
$41
Kaleo, Inc.
$40
Nalu Medical, Inc.
$40
DePuy Synthes Sales Inc.
$38
TerSera Therapeutics LLC
$36
Forte Bio-Pharma LLC
$34
AstraZeneca Pharmaceuticals LP
$32
Sentynl Therapeutics, Inc.
$31
Medtronic USA, Inc.
$28
Purdue Pharma L.P.
$25
Baudax Bio Inc.
$20
Azurity Pharmaceuticals, Inc.
$20
Vertiflex, Inc.
$20
MML US, Inc.
$19
Radius Health, Inc.
$16
Vertical Pharmaceuticals, LLC
$16
Virtus Pharmaceuticals LLC
$15
Nuvectra Corporation
$15
SANOFI-AVENTIS U.S. LLC
$13
ConvaTec Inc.
$13
Alnylam Pharmaceuticals Inc.
$11
INSYS Therapeutics Inc
$11
Top 3 companies account for 35.0% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ANJESO · AQUACEL AG+ EXTRA · Aimovig · Algovita · BELBUCA · BOTOX · BUNAVAIL 2.1 mg 30-count box · Belbuca · Cambia · EMGALITY · EVZIO · FLECTOR · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GIVLAARI · GRALISE · HA MINUTEMAN G3-R · Horizant · INFINION · INTELLIS ADAPTIVESTIM · Intracept · LEVORPHANOL TARTRATE · LICART · LYRICA · Levorphanol · Licart · METHYLPHENIDATE 72 · MOVANTIK · Morphabond ER · Movantik · NAPRELAN · NURTEC ODT · Nalocet · Nalu Neurostimulation System · Nucynta · Nucynta ER · ORTHOVISC · Octrode SCS Leads · Omnia · PROCLAIM · PROLATE · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · Qutenza · RELISTOR · ReActiv8 · S-Series SCS Leads · SILENOR · SPECTRA WAVEWRITER · SPRIX · SUBSYS · SUPERION · SYMPROIC · SYNCHROMED · SYNCHROMEDII · SYNVISC-ONE · Senza · Senza II · Senza Spinal Cord Stimulation System · Superion · Superion ISS · Symproic · Trudhesa · Tymlos · UBRELVY · VERTECEM · XTAMPZA · ZIPSOR · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zipsor · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $573 per 100 Medicare services performed
Looking for a pain medicine specialist in Austin?
Compare pain medicines in the Austin area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
27
Per 100K population
2.1
County median income
$97,169
Nearest hospital
NORTHWEST HILLS SURGICAL HOSPITAL
2.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Blauzvern is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Blauzvern experienced with drug screening test?
Based on Medicare claims data, Dr. Blauzvern performed 630 drug screening test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Blauzvern receive payments from pharmaceutical companies?
Yes. Dr. Blauzvern received a total of $10,829 from 59 companies across 393 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Blauzvern's costs compare to other pain medicines in Austin?
Dr. Blauzvern's average Medicare payment per service is $121. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Blauzvern) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →